Back
Karyopharm Therapeutics Stock Price Chart
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free
Sell
45
KPTI
Karyopharm Therapeutics
Last Price:
$0.72
Seasonality Move:
6.51%
7 Day Trial
ALL ACCESS PASS
$
7
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing slight buying pressure.
Karyopharm Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.75 | Sell |
| 20-day SMA: | 0.7 | Buy |
| 50-day SMA: | 0.78 | Sell |
| 200-day SMA: | 0.92 | Sell |
| 8-day EMA: | 0.74 | Sell |
| 20-day EMA: | 0.73 | Sell |
| 50-day EMA: | 0.76 | Sell |
| 200-day EMA: | 0.94 | Sell |
Karyopharm Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 48.08 | Sell |
| Chaikin Money Flow: | 99913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.65 - 0.77) | Buy |
| Bollinger Bands (100): | (0.71 - 0.87) | Sell |
Karyopharm Therapeutics Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karyopharm Therapeutics Stock
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 0.72 while KPTI 8-day simple moving average is 0.75, which is a Sell signal.
-
The stock price of KPTI is 0.72 while Karyopharm Therapeutics 20-day SMA is 0.70, which makes it a Buy.
-
Karyopharm Therapeutics 50-day simple moving average is 0.78 while KPTI share price is 0.72, making it a Sell technically.
-
KPTI stock price is 0.72 and Karyopharm Therapeutics 200-day simple moving average is 0.92, creating a Sell signal.
KPTI Technical Analysis vs Fundamental Analysis
Sell
45
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy or a Sell?
-
Karyopharm Therapeutics stock is rated a SellThe current Karyopharm Therapeutics [KPTI] share price is $0.72. The Score for KPTI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Karyopharm Therapeutics Stock Info
Market Cap:
90.1M
Price in USD:
0.72
Share Volume:
845.2K
Karyopharm Therapeutics 52-Week Range
52-Week High:
1.95
52-Week Low:
0.58
Sell
45
Karyopharm Therapeutics (KPTI)
is a Sell
Karyopharm Therapeutics Share Price Forecast
-
What is the Karyopharm Therapeutics stock price today?The Karyopharm Therapeutics stock price is 0.72 USD today.
-
Will KPTI stock go up or go down?Karyopharm Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Karyopharm Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics is overvalued.
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 0.72 while KPTI 8-day exponential moving average is 0.74, which is a Sell signal.
-
The stock price of KPTI is 0.72 while Karyopharm Therapeutics 20-day EMA is 0.73, which makes it a Sell.
-
Karyopharm Therapeutics 50-day exponential moving average is 0.76 while KPTI share price is 0.72, making it a Sell technically.
-
KPTI stock price is 0.72 and Karyopharm Therapeutics 200-day simple moving average is 0.94, creating a Sell signal.
Fundamental Analysis of Karyopharm Therapeutics
Is Karyopharm Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.36 per share.
Technical Analysis of Karyopharm Therapeutics
Should I short Karyopharm Therapeutics stock?
-
KPTI Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Karyopharm Therapeutics is a Sell
-
Karyopharm Therapeutics Relative Strength Index (RSI) is 48.08, which suggest Karyopharm Therapeutics is oversold
-
The Bollinger Bands (25) for Karyopharm Therapeutics is (0.65 - 0.77), which suggest Karyopharm Therapeutics is a Sell
-
The Bollinger Bands (100) for Karyopharm Therapeutics is (0.71 - 0.87), which suggest Karyopharm Therapeutics is a Sell
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.